The polycythemia vera market over the next few years is expected to substantially change and experience growth, as it will be dominated by two already approved products, Incyte/Novartis' JAKAFI ...

Polycythemia Vera is a rare disorder marked by a continuous rise in the number of red blood cells in the blood, with an accompanying increase in white blood cells and platelets. It is the most ...

Sickle cell disease (SCD), the most common inherited blood disorder, affects millions worldwide. In the United States alone, ...

The underutilization of disease-modifying therapy by people with sickle cell disease is “persistent and alarming,” according ...

Alex Sapir; President, Chief Executive Officer, Director; Fulcrum Therapeutics Inc. Alan Musso; Chief Financial Officer, Treasurer; Fulcrum Therapeutics Inc. Lain Fr ...

Oppenheimer analyst Matthew Biegler met with Fulcrum Therapeutics (FULC)’ management Tuesday after the company reported year-end financials.

Government think tank NITI Aayog has formed a committee to create a roadmap aimed at transforming AIIMS, New Delhi, into a ...

TANZANIA: SICKLE Cell Disease (SCD) remains a significant health burden, particularly in Africa where approximately 80 per ...

The future of medicine with CRISPR and CAR-T therapy, exploring ethical, societal, and accessibility challenges in healthcare ...

The mandate of committee led by NITI Aayog member V K Paul involves thoroughly examining the existing systems and processes at AIIMS and proposing significant reforms along with specific timelines for ...

Sickle cell disease is a severe, inherited blood disorder that primarily affects people of African, Mediterranean, Middle ...